Mental illness does not discriminate age, gender or race. Up to 50% of mental health patients fail their first treatment plan. Genomind Professional PGx Express is designed to change that...
Up to 50% of patients fail their first treatment plan. Genomind's breatkthrough mental health genetic test was designed to change that. Click here to learn more...
![]() Dr. Ronald Dozoretz, MD |
Developed by Clinicians for CliniciansOur founders are world renowned clinicians and scientists with a legacy in compassionate patient care and psychiatric innovation - core values that guide our commitment to giving clinicians the most progressive tools that can help improve the lives of people with mental illness. |
Nearly 1 in 5 individuals suffer from mental illness, and many experience a painful process of treatment by trial and error. Our mission is to improve the quality of life for people with mental illness by using innovative technologies and collaborative expertise to advance personalized treatment plans. We will do this by empowering clinicians with unmatched genetic guidance designed to improve patient outcomes.
As a mental health education and technology leader, Genomind® is recognized as a global authority in the genetics of mental health.
“FASTEST-GROWING U.S. PRIVATE FIRMS” | ![]()
|
“BEST PLACES TO WORK IN HEALTHCARE” | ![]()
|
"2017 HEALTHCARE INNOVATOR AWARD” | ![]()
|
“EMERGING COMPANY OF THE YEAR” | ![]()
|
Our founders are world renowned clinicians and scientists with a legacy of compassionate patient care and psychiatric innovation -- core values that guide our commitment to give clinicians the most progressive tools that can help improve the lives of people with mental illness.
Read more about the experts who are the driving force behind our advances in mental health.
Ronald I. Dozoretz, MD is the Founder and Chairman of Genomind. He is a recognized national leader and advocate for...
As Chief Executive Officer, Mr. O’Brien is responsible for setting the strategy and delivering on the full financial potential of...
As the President of Genomind, Mr. Olmstead works with all the leaders to enhance overall company strategy...
As Senior Vice President and Chief Financial Officer, Mr. Hess is responsible for overall financial...
Dr. David Krause is Chief Medical Officer at Genomind. Board certified in internal medicine, Dr. Krause has more than...
Dr. Robbins serves as Chief Scientific Officer and is responsible for all aspects of laboratory operations at Genomind...
As Chief Information Officer, Mr. Levine is responsible for all aspects of our information technology, services...
As the US Sales Leader for Genomind, Ms. Miles is responsible for developing and executing the sales...
Dr. Aaronson specializes in treatment-resistant affective disorders. He is a thought leader in the areas of biological psychiatry, diagnosis and the integration of somatic and psychological therapies...
Dr. Ruth Benca is the Chair of Psychiatry and Human Behavior at the University of California Irvine (UCI), where she has built a comprehensive sleep medicine center focused on providing...
Dr. Kathleen Brady serves as the Vice President for Research at the Medical University of South Carolina (MUSC). She is an experienced clinical and translational researcher who has been working...
Stephen Faraone, PhD, is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University and Director of Research for the...
Dr. Fava is Director, Division of Clinical Research of the Massachusetts General Hospital (MGH) Research Institute, Executive Vice Chair of the Department of Psychiatry...
Dr. Malhotra is the Director of Psychiatry Research at the Zucker Hillside Hospital in Glen Oaks, NY, Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine (AECOM) in...
Dr. Perlis’ clinical work and research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder. He is the author of more than...
Dr. Naomi M. Simon is Professor of Psychiatry at NYU School of Medicine, Vice Chair for Research Faculty Development and Mentorship, and Director of the Anxiety and Complicated Grief...
An author of over 425 articles and more than 1500 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry...
Mark A. Stein, PhD, ABPP, is the Director of PEARL Clinic/ADHD and Related Disorders Program at Seattle Children’s Hospital and an Investigator at Seattle Children’s Research Institute...